Poised to Reshape Treatment Landscape: The Phase 3 Clinical Trial of Disitamab Vedotin as a First-Line Therapy for HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma Reached its Primary Endpoints of PFS and OS
YANTAI, China, May 12, 2025 /PRNewswire/ -- On May 12th, 2025, RemeGen Co., Ltd. ("RemeGen", stock symbols: 688331.SH/09995.HK) announced that its phase 3 clinical trial (Study ID: RC48-C016) on disitamab vedotin (DV, brand name: 爱地希®), the first...
State Grid Bortala Electric Power Supply Company Ensures Smooth Railway Transport During the Spring Festival Travel Rush
BORTALA, China, Jan. 22, 2025 /PRNewswire/ -- On January 20, State Grid Bortala Electric Power Supply Company organized a team of employees to conduct inspections on the 110 kV Huanggu transmission line, ensuring its safe and stable operation during...
Hetian Minfeng 220 kV Power Transmission and Transformation Project: comprehensive self-inspection and defect rectification work across the entire line initiated
HETIAN, China, Nov. 22, 2024 /PRNewswire/ -- On November 20, the 220kV transmission and transformation project in Minfeng County, Hetian, carried out a comprehensive self-inspection and defect rectification across the entire line. The line section...
2024 WIC & Light of Internet Expo Kicks off in Wuzhen, Zhejiang
WUZHEN, China, Nov. 21, 2024 /PRNewswire/ -- A news report from CRIOnline: The 2024 World Internet Conference & Light of Internet Expo (WICEXPO) kicked off in Wuzhen on November 19, 2024. As an important part of the World Internet Conference...